Latest in Finance

Merck attains $588m global license for PD-1/VEGF bispecific antibody from LaNova Medicines

The bispecific antibody is designed for oncological indications and functions by inhibiting the PD-1/PD-L1 and the VEGF/VEGFR receptor signalling pathways

Find out more

Transmission Raman Spectroscopy - access the webinar series today

Offering significant advantages for bulk, quantitative and non-destructive analysis, Transmission Raman Spectroscopy is a preferred choice for applications where surface...
See more

Syncona launches early-stage drug development company, Slingshot Therapeutics

The novel early-stage pharmaceutical company aims to collaborate with academic institutions to bring their findings to the clinic, with their first programme centring around inflammatory disease

Ascend Advanced Therapies expands US footprint through Advanced BioScience Laboratories merger

Ascend's collaboration with EW Healthcare partners will expand its reach in the US pharmaceutical market through capital investment and an uptick in GMP AAV manufacturing capacity

AstraZeneca invests $3.5bn into its US pharmaceutical research and manufacturing capabilities

The company will expand its biologics manufacturing, as well as its speciality manufacturing and cell therapy production capacity, while also extending its pharmaceutical research and development capabilities through this investment

Evotec strikes up a deal with Monacum Partners to sell its Halle API manufacturing facility

The CDMO faction of Evotec will now function as DAPIN GmbH, which will continue to specialise in end-to-end chemical API development and manufacturing

MAP Group broadens its European market access platform by adding SKC to its portfolio of companies

The MAP Group has continued its international expansion with the acquisition of SKC Beratungsgesellschaft mbH, significantly increasing expertise and headcount and expanding its footprint into a key European market

Accord Healthcare bolsters UK drug manufacturing capabilities with £50m Newcastle facility

The novel automated facility will allow Accord to produce therapeutics for oncological and autoimmune diseases for the UK and beyond

Novo Nordisk acquires license to Ascendis Pharma's TransCon tech for up to $286m

Novo Nordisk will use the technology to develop, manufacture and commercialise therapeutics for metabolic and cardiovascular diseases

Novel innovation enhances productivity and output for Polish pharma company

A consultative approach to service, delivery and problem solving ensured that a Polish pharmaceutical company received the equipment and technology it needed to ramp up production and expand into new geographies

Latest posts in Finance

Merck bolsters its ADC CDMO offering with €71m Missouri manufacturing site expansion

The facility's expansion has tripled its ADC manufacturing capacity, bolstering Merck's CDMO offering for current and new clients

AbbVie to bolster its neuroscience pipeline with $1.4bn Aliada Therapeutics acquisition

The acquisition will add to AbbVie's Alzheimer's drug pipeline, while also allowing it access to Aliada's proprietary blood-brain barrier-crossing technology

Eli Lilly to leverage ViaNautis Bio's nanovesicle technology for genetic medicine development

ViaNautis' polyNaut nanovesicles can deliver genetic materials to specific tissues or cell types, allowing for more accurate therapeutic targeting

GSK bolsters its US drug manufacturing capabilities with $800m investment

The expansion will double the size and capacity of its Marietta site, supporting the manufacture of sterile liquid vaccines and production for clinical trials

Rentschler Biopharma begins construction on buffer media station for biologics manufacturing

The expansion will optimise the CDMO's process efficiency, while helping them to cater to global biopharmaceutical clients

Sanofi begins negotiations with CD&R to sell stake in Opella

Opella is currently estimated to be worth €16bn, and CD&R's stake will allow the consumer healthcare company to grow as a standalone business

Axol Bioscience boosts its iPSC bioassay offering with Phenocell acquisition

The acquisition will extend Axol's range of iPSC-derived cell lines, including skin and retinal cells — while also expanding its drug discovery services

NovaCina expands Perth facility to offer clinical supplies service for the global market

NovaCina has announced the expansion of its facility in Perth, Australia, with the introduction of a high-tech SA25 GMP filling line to assist customers with small-batch sizes suitable for all clinical phases

Ardena to expand US footprint with the acquisition of advanced drug product manufacturing facility from Catalent

Ardena, a specialist pharmaceutical CDMO with GMP facilities in Belgium, Spain, the Netherlands and Sweden, has signed a definitive agreement to acquire Catalent’s state-of-the-art facility in Somerset, New Jersey

Johnson & Johnson completes V-Wave acquisition to support patients with heart failure

The strategic acquisition will bolster the pharma giant's MedTech offerings for patients with cardiovascular disease

Aenova strengthens its development services to focus on preformulation and bioavailability enhancement

Aenova, one of the world's leading CDMOs, strengthens its development services in the areas of formulation and preformulation as well as clinical trial services

Bioduro-Sundia launches new compound management center, strengthening drug discovery services

BioDuro-Sundia, a leading global contract research, development and manufacturing organisation (CRDMO), has announced the launch of a new Compound Management Center at its Waigaoqiao site in the Shanghai Free-Trade Zone, China

Sponsor content

Vetter strengthens senior management team for growth

Three new managing directors to support global sustainable development

Piramal Pharma Limited reports robust growth in CDMO and sustainability initiatives

US$80 million Lexington expansion to double sterile fill-finish capacity

Piramal Pharma releases Q2 results for FY2025

The company's CDMO business is driving its growth significantly, with a 17% increase YoY

Actylis expands into VMS & Pharma with the acquisition of Pharm-Rx

The acquisition strengthens Actylis’ presence in the VMS and OTC markets

Ansell acquires Kimberley-Clark's personal protective equipment business

The novel acquisition will bolster Ansell's PPE offerings for customers in the laboratory and cleanroom environments

Medical devices spur growth for ByteSnap Design

Electronics design company employees boosted to 43 as a result of rapid expansion

Cumulus Oncology raises £9m in seed financing

Proceeds from the financing will be used to support Cumulus Oncology’s future growth plans, expand its portfolio and accelerate the development of new cancer treatments...

ADC Therapeutics regains compliance with NYSE continued listing standards

ADC Therapeutics (NYSE: ADCT) is a commercial-stage global leader and pioneer in the field of antibody drug conjugates (ADCs)

SGS joins forces with Agilex Biolabs

This collaboration marks a significant step in strengthening SGS’s global footprint in the bioanalysis services sector

CPHI Barcelona Snapshot: CordenPharma

At CPHI Barcelona, Dr Kevin Robinson talked to Dr Michael Quirmbach, CEO and President of CordenPharma, about the company’s recent activities and what lies ahead

Glox Therapeutics secures £4.3m seed funding to develop precision antimicrobials

Investment to accelerate development of a novel class of targeted high-potency bacteriocins against specific antimicrobial-resistant pathogens

AtkinsRéalis awarded engineering design services contract for API manufacturing facility in Singapore

When completed, the Singapore site will play a critical role in WuXi AppTec’s global network across Asia, Europe and North America, meeting the growing demand from...